Data demonstrate ATH434 slows disease progression and stabilizes orthostatic hypotension – – New analysis increases overall confidence in the Phase 2 trial results – – State-of-the-art neuroimaging ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback